Results

Halozyme Therapeutics Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 13:26

Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Carfilzomib and Dexamethasone for Patients[...]